Abstract | AIM: Recently, the atherogenic index of plasma (AIP) has been proposed as a novel, reliable plasma atherogenicity marker. This study aimed to investigate the association of AIP with the risk of in- stent restenosis (ISR) in patients with acute coronary syndrome (ACS). METHODS: RESULTS: This study recruited 1319 patients with ACS, 199 of which had ISR. Compared with the non-ISR group, patients in the ISR group had higher level of AIP (0.199±0.290 vs 0.131±0.282, p=0.002). In the multiple logistic regression analysis, AIP was an independent risk factor for DES-ISR (OR=2.100, 95% CI 1.134 to 3.891, p=0.018). When we modulated AIP as a categorical variable, the risk of DES-ISR increased in quartile 4 compared to quartile 1 (OR=1.713, 95% CI 1.040 to 2.822, p=0.034). Furthermore, this association remains stable in various subgroups. Unexpectedly, the subgroup analysis suggested AIP and DES-ISR had a stronger positive association in individuals with low-density lipoprotein cholesterol ( LDL-C) <1.8 mmol/L. CONCLUSIONS: AIP and the risk of DES-ISR were positively and independently correlated in patients with ACS, especially in those with an LDL-C <1.8 mmol/L.
|
Authors | Yong Zhu, Maolin Chen, Kesen Liu, Ang Gao, Xiangyun Kong, Yan Liu, Hongya Han, Hong Li, Huagang Zhu, Jianwei Zhang, Yingxin Zhao |
Journal | Journal of atherosclerosis and thrombosis
(J Atheroscler Thromb)
Vol. 29
Issue 8
Pg. 1226-1235
(Aug 01 2022)
ISSN: 1880-3873 [Electronic] Japan |
PMID | 34497172
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Acute Coronary Syndrome
(complications, etiology)
- Cholesterol, LDL
- Coronary Angiography
- Coronary Restenosis
(diagnosis, etiology)
- Drug-Eluting Stents
(adverse effects)
- Humans
- Percutaneous Coronary Intervention
- Retrospective Studies
- Risk Factors
- Treatment Outcome
|